Literature DB >> 23161509

Cholesterol screening and management in children and young adults should start early--NO!

Alan R Schroeder, Rita F Redberg.   

Abstract

In 2011, an expert panel from the National Heart, Lung, and Blood Institute released recommendations for universal lipid screening and treatment of high cholesterol in children. There is no evidence that universal screening will help children lead longer, healthier lives. These recommendations will, however, fuel the epidemic of overtreatment that is currently threatening our healthcare system and our patients.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23161509      PMCID: PMC6652346          DOI: 10.1002/clc.22075

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  5 in total

Review 1.  Does true Gleason pattern 3 merit its cancer descriptor?

Authors:  Saiful Miah; Hashim U Ahmed; Alex Freeman; Mark Emberton
Journal:  Nat Rev Urol       Date:  2016-08-17       Impact factor: 14.432

2.  Prevalence of dyslipidaemia and associated risk factors among Balearic Islands adolescents, a Mediterranean region.

Authors:  M M Bibiloni; R Salas; A Pons; J A Tur
Journal:  Eur J Clin Nutr       Date:  2014-10-29       Impact factor: 4.016

Review 3.  Management of hypercholesterolemia in children.

Authors:  Marjet J A M Braamskamp; Barbara A Hutten; Albert Wiegman; John J P Kastelein
Journal:  Paediatr Drugs       Date:  2014-04       Impact factor: 3.930

4.  Serum Lipid Profile, Prevalence of Dyslipidaemia, and Associated Risk Factors Among Northern Mexican Adolescents.

Authors:  Maria Del Mar Bibiloni; Rogelio Salas; Yolanda E De la Garza; Jesus Z Villarreal; Antoni Sureda; Josep A Tur
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-11       Impact factor: 2.839

Review 5.  A systematic review and meta-analysis on screening lipid disorders in the pediatric age group.

Authors:  Roya Kelishadi; Ali Akbar Haghdoost; Mahmood Moosazadeh; Mojtaba Keikha; Maryam Aliramezany
Journal:  J Res Med Sci       Date:  2015-12       Impact factor: 1.852

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.